Lipiview Ocular Surface Interferometer
Payments companies reported to CMS as associated with Lipiview Ocular Surface Interferometer. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Lipiview Ocular Surface Interferometer, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Lipiview Ocular Surface Interferometer
These are the largest totals companies reported as associated with Lipiview Ocular Surface Interferometer. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Casey Claypool | Spokane Valley, WA | Optometrist | $3,008.00 |
| Sahal Saleh | Edina, MN | Retina Specialist | $524.60 |
| Bryson Tudor | Grand Junction, CO | Ophthalmology | $524.60 |
| Bohan Xing | Tucson, AZ | Ophthalmology | $524.60 |
| Anthony Mai | Sioux Falls, SD | Ophthalmology | $524.60 |
| Katherine Chen | Irvine, CA | Ophthalmology | $524.60 |
| Grace Su | San Jose, CA | Ophthalmology | $524.60 |
| Mariana Abi Karam | Miami, FL | Pediatric Ophthalmology and Strabismus Specialist | $524.60 |
| Joanne Choi | San Francisco, CA | Cornea and External Diseases Specialist | $262.30 |
| Akaanksh Shetty | Sebring, FL | Ophthalmology | $262.30 |
Prescribed Lipiview Ocular Surface Interferometer?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.